Cencora (COR) stock
NYSE
As of the Nov 5, 2026 close (U.S. Eastern)
Events and reference metrics · 1
- Market cap
- $64.9B
- As of Nov 5, 2026
- P/E
- 24.72x
- Trailing twelve months
- P/B
- 21.26x
- Latest reported equity
- P/S
- 0.19x
- Trailing twelve months
- ROE
- 86.0%
- Trailing twelve months
- Dividend yield
- 0.65%
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
- Market cap
- $64.9B
- As of Nov 5, 2026
- P/E
- 24.72x
- Trailing twelve months
- P/B
- 21.26x
- Latest reported equity
- P/S
- 0.19x
- Trailing twelve months
- ROE
- 86.0%
- Trailing twelve months
- Dividend yield
- 0.65%
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 5, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
24.72x
P/B
21.26x
P/S
0.19x
Earnings and dividend metrics▾
Earnings
EPS
$13.74
Earnings per share
BPS
$15.97
Book value per share
ROE
86.0%
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $13.74 per share.
- BPS — net assets divided by the number of shares. Each share is backed by $15.97 of net assets.
- ROE — how much the company earned on shareholder equity over a year: 86.0%.
Dividends
Yield
0.65%
Dividend per share
$2.20
Payout ratio
16.6%
Consecutive years
18+ yrs
Yield uses fiscal 2025 dividends · Dividend per share and payout ratio are for fiscal 2025.
- Dividend yield — dividends divided by the share price (or market cap). It falls when the price rises.
- Dividend per share — the fiscal-year dividend per share. For one hundred shares that is about $220.00 before tax.
- Payout ratio — 16.6% of earnings was paid out as dividends.
- Consecutive years — dividends were paid every year for more than 18 years. That does not mean they will continue.
Reference only · not a promise of future dividends
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsApr–Jun 2026(FY2026 Q3)
Revenue increased 5.1% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $80.7B+5.1%
$74.2B
Apr–Jun '24
$80.7B
Apr–Jun '25
$84.8B
Apr–Jun '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Apr–Jun 2026 are from the 10-Q submitted to SEC EDGAR on Aug 5, 2026.
- Earnings per share increased 11.9% from the same quarter a year earlier.
- Revenue increased 5.1% from the same quarter a year earlier.
- Operating income increased 29.0% from the same quarter a year earlier.
- Net income increased 11.2% from the same quarter a year earlier.
Filed Aug 5, 2026 · 10-Q · SEC EDGAR · View original
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Krikorian LazarusSVP & Chief Accounting Officer · Nov 2, 2026Open-market sale986 shares · $326KAvg. price $330.9614,197 shares held after
- Verma PawanEVP, Chief Data & Info Officer · Oct 30, 2026Shares withheld for taxes4,254 shares · $1.4MAvg. price $330.849,432 shares held after
- NALLY DENNIS MDirector · Oct 30, 2026Grant or award106 shares · $35KAvg. price $330.8413,294 shares held after
- Cooper EllenDirector · Oct 30, 2026Grant or award91 shares · $30KAvg. price $330.84984 shares held after
- Tyler Lauren MDirector · Oct 30, 2026Grant or award91 shares · $30KAvg. price $330.844,547 shares held after
- Verma PawanEVP, Chief Data & Info Officer · Oct 30, 2026Option exercise8,538 shares · $0Avg. price $013,686 shares held after
- Krikorian LazarusSVP & Chief Accounting Officer · Oct 1, 2026Open-market sale986 shares · $299KAvg. price $303.1815,183 shares held after
- SANCHEZ ROBERT EDirector · Oct 1, 2026Grant or award275 shares275 shares held after
- GREENBERG LON RDirector · Sep 16, 2026Open-market sale1,280 shares · $411KAvg. price $321.317,128 shares held after
- Krikorian LazarusSVP & Chief Accounting Officer · Sep 1, 2026Open-market sale985 shares · $321KAvg. price $325.9716,169 shares held after
- Campbell Elizabeth SExecutive Vice President · Aug 24, 2026Open-market sale11,300 shares · $3.7MAvg. price $324.11619,455 shares held after
- NALLY DENNIS MDirector · Jul 31, 2026Grant or award113 shares · $35KAvg. price $311.3413,188 shares held after
- Cooper EllenDirector · Jul 31, 2026Grant or award97 shares · $30KAvg. price $311.34893 shares held after
- Tyler Lauren MDirector · Jul 31, 2026Grant or award97 shares · $30KAvg. price $311.344,456 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary8-KCencora said its reporting structure will consist of Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other beginning in the Q1 of fiscal 2027. The company said the change reflects a reorganization of all business components within its U.S. Healthcare Solutions and International Healthcare Solutions reportable segments.Published Nov 4, 2026 · Filed Nov 4, 2026Read the summary →
- AI summary8-KCencora said revenue for fiscal 2026 Q4 (ended September 30) rose 5.5% to $88.4 billion. It said GAAP diluted EPS was $2.71 and adjusted diluted EPS was $4.66. GAAP diluted EPS for the same quarter of the prior year was $(1.75).Published Nov 4, 2026 · Filed Nov 4, 2026Read the summary →
- AI summary8-KThe company said it agreed under a merger agreement signed on October 20, 2026 to acquire all of the equity interests in American Oncology Network (AON) that it does not already own, and that it currently holds about 4% of AON.Published Oct 21, 2026 · Filed Oct 21, 2026Read the summary →
- Cencora said its reporting structure will consist of Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other beginning in the Q1 of fiscal 2027. The company said the change reflects a reorganization of all business components within its U.S. Healthcare Solutions and International Healthcare Solutions reportable segments.Read the full analysis →
- Cencora said revenue for fiscal 2026 Q4 (ended September 30) rose 5.5% to $88.4 billion. It said GAAP diluted EPS was $2.71 and adjusted diluted EPS was $4.66. GAAP diluted EPS for the same quarter of the prior year was $(1.75).Read the full analysis →
- The company said it agreed under a merger agreement signed on October 20, 2026 to acquire all of the equity interests in American Oncology Network (AON) that it does not already own, and that it currently holds about 4% of AON.Read the full analysis →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Cencora (COR) stock information
NYSE
Cencora (COR) is listed on NYSE. Its market capitalization is about $64.9B. On trailing-twelve-month earnings the P/E ratio is 24.72, and the P/B ratio is 21.26. Return on equity is 86%. These figures are computed in-house from official filings and are reference information only.
Cencora — frequently asked questions
- What is the P/E ratio of Cencora (COR)?
- On a trailing-twelve-month basis, COR trades at a P/E ratio of 24.72. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Cencora?
- COR has a market capitalization of about $64.9B. The figure moves with the share price and is refreshed each trading day.
- Does Cencora pay a dividend?
- COR has a dividend yield of about 0.65%, based on disclosed payment history. Dividend policy can change; this is reference information only.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.